|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 罗拉吡坦>> 市场分析报告 |
罗拉吡坦市场分析报告 |
|
Opko Health, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... and Related Markets NK-1 Program Rolapitant: The companys primary product ... candidate, rolapitant, a potent and selective competitive ... final development and commercialization of rolapitant for both indications. NK-1 receptors ... Global CINV Existing and Pipeline Drugs Market Status, Trends and COVID-19 Impact Report 2022 ... Kytril Generic Emend Akynzeo/SUSTOL/Rolapitant Application Segment Hospitals Specialty Clinics ... Global CINV Existing and Pipeline Drugs Market Growth 2024-2030 ... Kytril Generic Emend Akynzeo SUSTOL Rolapitant Segmentation by application Hospitals Specialty Clinics ... Global NK1 Receptor Antagonist Market Growth 2025-2031 ... and countries. Segmentation by Type: Aprepitant Rolapitant Fosaprepitant Netupitant Maropitant Other Segmentation ... Global CINV Existing and Pipeline Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... Kytril Generic Emend Akynzeo SUSTOL Rolapitant Market segment by Application Hospitals Specialty ... Chemotherapy-Induced Nausea and Vomiting Drugs Market - Global Outlook and Forecast 2022-2028 ... SUSTOL (Granisetron Injection extended release) Rolapitant Global Chemotherapy-Induced Nausea and ... CINV Existing and Pipeline Drugs Market, Global Outlook and Forecast 2022-2028 ... Kytril Generic Emend Akynzeo SUSTOL Rolapitant Global CINV Existing and Pipeline ... India Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Injectables), By Manufacturing Type (In-house, Contract), By Therapeutic Category (Endrocrinology, Cardiovascular), And Segment Forecasts, 2024 - 2030 This report can be delivered to the clients within 2 Business Days India Pharmaceutical Manufacturing Market Growth & Trends The India pharmaceutical manufacturing market size is expected to reach USD 35.38 billion by 2030, growing at a CAGR of 10.5%, ... Global Cinv Existing And Pipeline Drugs Market Research Report 2025(Status and Outlook) ... Kytril Generic Emend Akynzeo SUSTOL Rolapitant Market Segmentation (by Application) Hospitals Specialty ... Global Chemotherapy Induced Nausea and Vomiting Drugs Market Research Report 2023(Status and Outlook) ... SUSTOL (Granisetron Injection extended release) Rolapitant Market Segmentation (by Application) Serotonin Receptor ... 2023-2028 Global and Regional CINV Existing and Pipeline Drugs Industry Status and Prospects Professional Market Research Report Standard Version ... ) SUSTOL (extended release granisetron injection) Rolapitant By Applications: Hospitals Specialty Clinics Diagnostic ... Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled "Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and ... Innovative drugs: Mapping the pricing, reimbursement and HTA landscape ... Palbociclib Pimavanserin Plecanatide Reslizumab Ribociclib Rolapitant Rucaparib Safinamide Sarilumab Selexipag Sofosbuvir ... TESARO Inc (TSRO) - Financial and Strategic SWOT Analysis Review ... , or primary peritoneal cancer and VARUBI (rolapitant) for the prevention of chemotherapy induced ... |